Stocks and Investing Stocks and Investing
Fri, April 21, 2023
[ 12:00 AM ] - United States, WOPRAI
Geoff Meacham Maintained (BMY) at Strong Buy with Increased Target to $85 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Robert Mason Maintained (BMI) at Hold with Increased Target to $125 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Tate Sullivan Maintained (BMI) at Strong Buy with Increased Target to $152 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Nathan Jones Maintained (BMI) at Hold with Increased Target to $126 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Taylor McGinnis Initiated (BILL) at Strong Buy and Held Target at $95 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Mario Lu Maintained (BKNG) at Buy on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Abhishek Kumar Maintained (BKR) at Strong Buy with Increased Target to $40 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Stan Berenshteyn Maintained (ACCD) at Hold with Increased Target to $13 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Lucas Pipes Maintained (AA) at Hold with Decreased Target to $43 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Samuel Bland Downgraded (ZIM) to Hold and Decreased Target to $21 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Matthew Murphy Maintained (AEM) at Buy with Increased Target to $63 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Arthur He Reiterated (ADAG) at Strong Buy and Held Target at $5 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Jon Arfstrom Reiterated (ASB) at Hold and Held Target at $21 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
David Nierengarten Reiterated (ARGX) at Buy and Held Target at $432 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Justin Jenkins Maintained (ARIS) at Buy with Decreased Target to $14 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Neil Mehta Maintained (AR) at Strong Buy with Increased Target to $34 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Swayampakula Ramakanth Initiated (AVGR) at Strong Buy and Held Target at $24 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Gil Blum Reiterated (AUTL) at Strong Buy and Held Target at $7 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Bill Sutherland Maintained (AUGX) at Strong Buy with Increased Target to $6 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Allen Klee Maintained (AUGX) at Strong Buy with Increased Target to $8 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
David Chiaverini Maintained (CATY) at Buy with Decreased Target to $40 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Vedvati Shrotre Initiated (CAMT) at Strong Buy and Held Target at $35 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Leo Mariani Maintained (CALX) at Strong Buy with Decreased Target to $73 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Mike Genovese Maintained (CALX) at Strong Buy with Decreased Target to $70 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Paul Silverstein Maintained (CALX) at Buy with Increased Target to $79 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Brandt Montour Maintained (BYD) at Buy with Increased Target to $75 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Raghuram Selvaraju Reiterated (ANVS) at Strong Buy and Held Target at $40 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
John Freeman Maintained (APA) at Strong Buy with Increased Target to $53 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Neil Mehta Maintained (APA) at Hold with Increased Target to $40 on, Apr 21st, 2023
[ 12:00 AM ] - United States, WOPRAI
Matt Olney Reiterated (AMTB) at Hold and Held Target at $24 on, Apr 21st, 2023

Matt Olney Reiterated (AMTB) at Hold and Held Target at $24 on, Apr 21st, 2023


Published on 2024-10-28 02:56:03 - WOPRAI, Matt Olney
  Print publication without navigation


Matt Olney of Stephens & Co., Reiterated "Amerant Bancorp Inc." (AMTB) at Hold and Held Target at $24 on, Apr 21st, 2023.

Matt has made no other calls on AMTB in the last 4 months.



There is 1 other peer that has a rating on AMTB. Out of the 1 peers that are also analyzing AMTB, 0 agree with Matt's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matt

  • Michael Rose of "Raymond James" Maintained at Buy with Decreased Target to $28 on, Thursday, April 6th, 2023

Contributing Sources